{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:12:44Z","timestamp":1770833564845,"version":"3.50.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Diabetes is defined by hyperglycaemia due to progressive insulin resistance and compromised insulin release. In parallel, alpha cells develop dysregulation of glucagon secretion. Diabetic patients have insufficient glucagon secretion during hypoglycaemia and a lack of inhibition of glucagon secretion at higher blood glucose levels resulting in postprandial hyperglucagonaemia, which contributes to the development of hyperglycaemia. Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an efficient pharmacologic approach for the treatment of hyperglycaemia in type 2 diabetes. While SGLT2 inhibitors aim at increasing glycosuria to decrease blood glucose levels, these inhibitors also increase circulating glucagon concentrations. Here, we review recent advances in our understanding of how SGLTs are involved in the regulation of glucagon secretion. Sodium plays an important role for alpha cell function, and a tight regulation of intracellular sodium levels is important for maintaining plasma membrane potential and intracellular pH. This involves the sodium-potassium pump, sodium-proton exchangers and SGLTs. While the expression of SGLT2 in alpha cells remains controversial, SGLT1 seems to play a central role for alpha cell function. Under hyperglycaemic conditions, SGLT1 mediated accumulation of sodium results in alpha cell dysregulation due to altered cellular acidification and ATP production. Taken together, this suggests that SGLT1 could be a promising, yet highly underappreciated drug target to restore alpha cell function and improve treatment of both type 1 and 2 diabetes.<\/jats:p>","DOI":"10.3389\/fphar.2022.837664","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T06:24:27Z","timestamp":1644819867000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters"],"prefix":"10.3389","volume":"13","author":[{"given":"Sarah L.","family":"Armour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Frueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob G.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.2337\/dc09-S062","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc09-S062","article-title":"Diagnosis and Classification of Diabetes Mellitus","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.2337\/diabetes.51.4.958","article-title":"Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response","volume":"51","author":"Banarer","year":"2002","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e15009","DOI":"10.14814\/phy2.15009","article-title":"Mini-review: Glucagon Responses in Type 1 Diabetes - a Matter of Complexity","volume":"9","author":"Bengtsen","year":"2021","journal-title":"Physiol. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the Glucose Transporter SGLT2 with Dapagliflozin in Pancreatic Alpha Cells Triggers Glucagon Secretion","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/03009734.2016.1156789","article-title":"Glucagon Secretion from Pancreatic \u03b1-cells","volume":"121","author":"Briant","year":"2016","journal-title":"Ups J. Med. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1016\/j.celrep.2018.05.035","article-title":"CPT1a-Dependent Long-Chain Fatty Acid Oxidation Contributes to Maintaining Glucagon Secretion from Pancreatic Islets","volume":"23","author":"Briant","year":"2018","journal-title":"Cell Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.celrep.2018.02.032","article-title":"\u03b1 Cell Function and Gene Expression Are Compromised in Type 1 Diabetes","volume":"22","author":"Brissova","year":"2018","journal-title":"Cel Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2337\/dc14-0315","article-title":"Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients with Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension","volume":"38","author":"Cefalu","year":"","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00125-015-3547-2","article-title":"Effects of Canagliflozin on Body Weight and Relationship to HbA1c and Blood Pressure Changes in Patients with Type 2 Diabetes","volume":"58","author":"Cefalu","year":"","journal-title":"Diabetologia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101071","DOI":"10.1016\/j.molmet.2020.101071","article-title":"SGLT2 Is Not Expressed in Pancreatic \u03b1- and \u03b2-cells, and its Inhibition Does Not Directly Affect Glucagon and Insulin Secretion in Rodents and Humans","volume":"42","author":"Chae","year":"2020","journal-title":"Mol. Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.2147\/DDDT.S114932","article-title":"Spotlight on Ertugliflozin and its Potential in the Treatment of Type 2 Diabetes: Evidence to Date","volume":"11","author":"Cinti","year":"2017","journal-title":"Drug Des. Devel Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.2337\/db10-0728","article-title":"Insulin Reciprocally Regulates Glucagon Secretion in Humans","volume":"59","author":"Cooperberg","year":"2010","journal-title":"Diabetes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in Diabetes","volume":"26","author":"Cryer","year":"2003","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia: The Limiting Factor in the Glycaemic Management of Type I and Type II Diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1463-1326.2011.01511.x","article-title":"The Role of the Kidneys in Glucose Homeostasis: A New Path towards Normalizing Glycaemia","volume":"14","author":"DeFronzo","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic Response to Sodium-Glucose Cotransporter 2 Inhibition in Type 2 Diabetic Patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2337\/dbi19-0004","article-title":"Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes","volume":"69","author":"Finan","year":"2020","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/en.2007-1088","article-title":"Na(+) -glucose Transporter-2 Messenger Ribonucleic Acid Expression in Kidney of Diabetic Rats Correlates with Glycemic Levels: Involvement of Hepatocyte Nuclear Factor-1alpha Expression and Activity","volume":"149","author":"Freitas","year":"2008","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1126\/science.182.4108.171","article-title":"Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect","volume":"182","author":"Gerich","year":"1973","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2337\/db11-1029","article-title":"Na(+)-D-glucose Cotransporter SGLT1 Is Pivotal for Intestinal Glucose Absorption and Glucose-dependent Incretin Secretion","volume":"61","author":"Gorboulev","year":"2012","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1210\/er.2006-0007","article-title":"Alpha-cells of the Endocrine Pancreas: 35 Years of Research but the enigma Remains","volume":"28","author":"Gromada","year":"2007","journal-title":"Endocr. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/dom.12958","article-title":"Treatment with LY2409021, a Glucagon Receptor Antagonist, Increases Liver Fat in Patients with Type 2 Diabetes","volume":"19","author":"Guzman","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/03009734.2016.1154905","article-title":"Glucose Control of Glucagon Secretion-'There's a Brand-New Gimmick Every Year'","volume":"121","author":"Gylfe","year":"2016","journal-title":"Ups J. Med. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2337\/db08-0792","article-title":"Somatostatin Secreted by Islet delta-cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function","volume":"58","author":"Hauge-Evans","year":"2009","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1074\/jbc.270.15.8971","article-title":"Differences in Glucose Transporter Gene Expression between Rat Pancreatic Alpha- and Beta-Cells Are Correlated to Differences in Glucose Transport but Not in Glucose Utilization","volume":"270","author":"Heimberg","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1463-1326.2012.01580.x","article-title":"The Pharmacokinetics and Pharmacodynamics of Rapid-Acting Insulin Analogues and Their Clinical Consequences","volume":"14","author":"Home","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2337\/diabetes.53.6.1488","article-title":"Regulation of Alpha-Cell Function by the Beta-Cell in Isolated Human and Rat Islets Deprived of Glucose: The \"switch-Off\" Hypothesis","volume":"53","author":"Hope","year":"2004","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"C14","DOI":"10.1152\/ajpcell.00388.2010","article-title":"Glucose Transport by Human Renal Na+\/D-Glucose Cotransporters SGLT1 and SGLT2","volume":"300","author":"Hummel","year":"2011","journal-title":"Am. J. Physiol. Cel Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"E1107","DOI":"10.1152\/ajpendo.00207.2012","article-title":"SSTR2 Is the Functionally Dominant Somatostatin Receptor in Human Pancreatic \u03b2- and \u03b1-cells","volume":"303","author":"Kailey","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1172\/jci110283","article-title":"Fluctuations of Calcium, Phosphorus, Sodium, Potassium, and Chlorine in Single Alpha and Beta Cells during Glucose Perifusion of Rat Islets","volume":"68","author":"Kalkhoff","year":"1981","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.2337\/dci16-0030","article-title":"Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249","volume":"39","author":"Kazda","year":"2016","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"101021","DOI":"10.1016\/j.molmet.2020.101021","article-title":"Reduced Somatostatin Signalling Leads to Hypersecretion of Glucagon in Mice Fed a High-Fat Diet","volume":"40","author":"Kellard","year":"2020","journal-title":"Mol. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cmet.2018.10.003","article-title":"Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-dependent Reduction of ATP Production","volume":"29","author":"Knudsen","year":"2019","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00125-019-4849-6","article-title":"No Direct Effect of SGLT2 Activity on Glucagon Secretion","volume":"62","author":"Kuhre","year":"2019","journal-title":"Diabetologia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ceca.2003.10.002","article-title":"A Store-Operated Mechanism Determines the Activity of the Electrically Excitable Glucagon-secreting Pancreatic Alpha-Cell","volume":"35","author":"Liu","year":"2004","journal-title":"Cell Calcium"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1371\/journal.pbio.0050143","article-title":"A K ATP Channel-dependent Pathway within Alpha Cells Regulates Glucagon Release from Both Rodent and Human Islets of Langerhans","volume":"5","author":"MacDonald","year":"2007","journal-title":"Plos Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1172\/JCI106445","article-title":"Glucagon Levels and Metabolic Effects in Fasting Man","volume":"49","author":"Marliss","year":"1970","journal-title":"J. Clin. Invest."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2337\/dbi18-0019","article-title":"Navigating the Depths and Avoiding the Shallows of Pancreatic Islet Cell Transcriptomes","volume":"68","author":"Mawla","year":"2019","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2337\/diabetes.55.04.06.db05-1449","article-title":"Postprandial Suppression of Glucagon Secretion Depends on Intact Pulsatile Insulin Secretion: Further Evidence for the Intraislet Insulin Hypothesis","volume":"55","author":"Meier","year":"2006","journal-title":"Diabetes"},{"key":"B41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin Improves Muscle Insulin Sensitivity but Enhances Endogenous Glucose Production","volume":"124","author":"Merovci","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molmet.2018.05.011","article-title":"Altered Pancreatic Islet Morphology and Function in SGLT1 Knockout Mice on a Glucose-Deficient, Fat-Enriched Diet","volume":"13","author":"Muhlemann","year":"2018","journal-title":"Mol. Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/s41467-020-15717-8","article-title":"Paracrine Control of \u03b1-cell Glucagon Exocytosis Is Compromised in Human Type-2 Diabetes","volume":"11","author":"Omar-Hmeadi","year":"2020","journal-title":"Nat. Commun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"dc211584","DOI":"10.2337\/dc21-1584","article-title":"Real-world Evidence of Efficacy and Safety of Sodium\u2013Glucose Cotransporter 2 Inhibitors as Adjunctive Therapy in Adults with Type 1 Diabetes: A European Two-Center Experience","author":"Palanca","year":"2022","journal-title":"Diabetes Care"},{"key":"B45","doi-asserted-by":"publisher","first-page":"31214","DOI":"10.1038\/srep31214","article-title":"Dapagliflozin Stimulates Glucagon Secretion at High Glucose: Experiments and Mathematical Simulations of Human A-Cells","volume":"6","author":"Pedersen","year":"2016","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"E117","DOI":"10.1152\/ajpendo.00439.2012","article-title":"Improved Glycemic Control in Mice Lacking Sglt1 and Sglt2","volume":"304","author":"Powell","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00008.2017","article-title":"Pancreatic \u03b2-Cell Electrical Activity and Insulin Secretion: Of Mice and Men","volume":"98","author":"Rorsman","year":"2017","journal-title":"Physiol. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2337\/db19-0888","article-title":"Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets","volume":"69","author":"Saponaro","year":"2020","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"165898","DOI":"10.1016\/j.bbadis.2020.165898","article-title":"HNF1\u03b1 Controls Glucagon Secretion in Pancreatic \u03b1-cells through Modulation of SGLT1","volume":"1866","author":"Sato","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"18572","DOI":"10.1074\/jbc.272.30.18572","article-title":"Metabolic Fate of Glucose in Purified Islet Cells. Glucose-Regulated Anaplerosis in Beta Cells","volume":"272","author":"Schuit","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1172\/JCI112784","article-title":"Relationship of Glucagon Suppression by Insulin and Somatostatin to the Ambient Glucose Concentration","volume":"79","author":"Starke","year":"1987","journal-title":"J. Clin. Invest."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2018.10.009","article-title":"SGLT1 in Pancreatic \u03b1 Cells Regulates Glucagon Secretion in Mice, Possibly Explaining the Distinct Effects of SGLT2 Inhibitors on Plasma Glucagon Levels","volume":"19","author":"Suga","year":"2019","journal-title":"Mol. Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1007\/s00125-009-1494-5","article-title":"Loss of Islet Sympathetic Nerves and Impairment of Glucagon Secretion in the NOD Mouse: Relationship to Invasive Insulitis","volume":"52","author":"Taborsky","year":"2009","journal-title":"Diabetologia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/j.gastro.2016.03.003","article-title":"Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via\u00a0Interleukin 6, Produced by \u03b1 Cells","volume":"151","author":"Timper","year":"2016","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI60016","article-title":"Glucagonocentric Restructuring of Diabetes: A Pathophysiologic and Therapeutic Makeover","volume":"122","author":"Unger","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1463-1326.2011.01450.x","article-title":"Regulation of Glucagon Secretion by Glucose: Paracrine, Intrinsic or Both?","author":"Walker","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.peptides.2017.12.001","article-title":"Alpha Cell Dysfunction in Type 1 Diabetes","volume":"100","author":"Yosten","year":"2018","journal-title":"Peptides"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1113\/JP279775","article-title":"'Resistance Is Futile?' - Paradoxical Inhibitory Effects of KATP Channel Closure in Glucagon-secreting \u03b1-cells","volume":"598","author":"Zhang","year":"2020","journal-title":"J. Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cmet.2013.10.014","article-title":"Role of KATP Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes","volume":"18","author":"Zhang","year":"2013","journal-title":"Cel Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.837664\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T06:24:32Z","timestamp":1644819872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.837664\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":60,"alternative-id":["10.3389\/fphar.2022.837664"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.837664","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"article-number":"837664"}}